Target intelligence / Profile preview

Nuclear receptor-binding factor 2 (NRBF2)

Target
NRBF2
Molecular classification
Autophagy-associated protein, PI3KC3-C1 complex subunit, Transcription coactivator, Other (multifunctional regulatory protein)
01

Overview

Nuclear receptor-binding factor 2 (NRBF2) is a multifunctional protein that acts as a tightly bound fifth subunit of the class III phosphatidylinositol 3-kinase complex I (PI3KC3-C1), central to autophagy initiation and regulation. NRBF2 directly enhances VPS34 lipid kinase activity and stabilizes PI3KC3-C1 assembly by interacting with subunits ATG14 and Beclin 1. It is also known to modulate transcription by interacting with nuclear receptors, and participates in synaptic plasticity and learning/memory processes in neurons, possibly through autophagy-independent mechanisms as well. NRBF2 has roles in neurodevelopment, autophagosome maturation, and is implicated in cognitive disorders, Alzheimer’s disease, and other neurodegenerative conditions. Loss or dysfunction of NRBF2 impairs autophagy and memory acquisition, and has been linked to disease phenotypes including dystonia and optic atrophy.

Other names
NRBF2COPRCOPR1COPR2NRBF-2DKFZp564C1664FLJ30395comodulator of PPAR and RXR 1comodulator of PPAR and RXR 2Comodulator of PPAR and RXR
02

Mechanism of action

Modulation of autophagy via Vps34/PI3KC3-C1 lipid kinase complex; Transcriptional coactivation for nuclear receptors

03

Biological functions

Autophagy initiation and regulationTranscriptional coactivation/modulationSynaptic plasticity and learning/memory formationNeural development and survival
04

Disease associations

Neurodegenerative disease (e.g., Alzheimer's disease)Cognitive disorders and learning/memory deficitsDystonia, childhood-onset, with optic atrophy, basal ganglia abnormalitiesPheochromocytoma
05

Safety considerations

Disruption may cause cognitive deficits, depression-like phenotypes, and impaired autophagy, as seen in knockout modelsPotential for off-target effects if autophagy pathways broadly affected
06

Interacting drugs

SAR405 (Vps34 inhibitor)

Beyond the preview

Go deeper on Nuclear receptor-binding factor 2 (NRBF2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nuclear receptor-binding factor 2 (NRBF2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call